πŸ‡ΊπŸ‡Έ FDA
Patent

US 9145389

Benzimidazole compound crystal

granted A61KA61K31/4439A61P

Quick answer

US patent 9145389 (Benzimidazole compound crystal) held by Takeda Pharmaceutical Company Limited expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Sep 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/4439, A61P, A61P1/00, A61P1/04